An important consideration in the development of assays is to determine the efficacy and toxicity of the compounds and the potency required to obtain a biological effect. A high potency is a key factor that would limit the high cost of synthesis and purification of such a compound. To illustrate the challenges in developing a synthetic endotoxin receptor antagonist we present the case of E5564.